Kevin Edward Yarasheski

Title: Kevin Edward Yarasheski: Innovator in Biomolecular Measurement

Introduction

Kevin Edward Yarasheski is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of biomolecular measurement, particularly in relation to neurological and neurodegenerative diseases. His work focuses on developing methods that enhance our understanding of biomolecules in biofluids.

Latest Patents

Yarasheski holds a patent for "Methods for measuring concentrations of biomolecules in biofluids." This invention provides innovative methods for measuring the absolute concentration of Tau and other protein, peptide fragments, and proteoforms in cerebrospinal fluid (CSF) and plasma samples collected from subjects. The methods are crucial for understanding the implications of these biomolecules in various neurological disorders. Additionally, the patent includes a method for determining whether a therapeutic agent affects the CSF or plasma concentration of central nervous system-derived biomolecules. The invention also encompasses kits designed for performing these methods.

Career Highlights

Kevin Edward Yarasheski is associated with C2N Diagnostics LLC, where he applies his expertise in biomolecular research. His work at the company emphasizes the importance of accurate biomolecular measurement in clinical settings. Yarasheski's innovative approach has positioned him as a key figure in the field of diagnostics.

Collaborations

Yarasheski collaborates with talented individuals such as Kristopher Michael Kirmess and Matthew R Meyer. Their combined efforts contribute to advancing research and development in biomolecular measurement.

Conclusion

Kevin Edward Yarasheski's contributions to the field of biomolecular measurement are invaluable. His innovative methods and dedication to research continue to impact the understanding of neurological diseases. His work exemplifies the importance of innovation in the medical and scientific communities.